دورية أكاديمية

Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.

التفاصيل البيبلوغرافية
العنوان: Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial.
المؤلفون: Dimopoulos, Meletios, Weisel, Katja, van de Donk, Niels W.C.J., Ramasamy, Karthik, Gamberi, Barbara, Streetly, Matthew, Offidani, Massimo, Bridoux, Frank, de la Rubia, Javier, Mateos, Maria-Victoria, Ardizzoia, Antonio, Kueenburg, Elisabeth, Collins, Shona, Di Micco, Antonia, Rosettani, Barbara, Li, Yan, Bacon, Pamela, Sonneveld, Pieter
المصدر: Journal of Clinical Oncology; 7/10/2018, Vol. 36 Issue 20, p2035-2043, 11p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2017.76.1742